Inovotion
2014
FOUNDED
PRIVATE
STATUS
Grant
LATEST DEAL TYPE
$55.2K
LATEST DEAL AMOUNT
3
INVESTORS
Description
Developer of vivo oncology efficacy and toxicity assays designed to optimise pre-clinical and discovery studies. The company's technology finds the best anticancer candidate treatment by detecting the first in vivo toxicity effects of candidate compounds, enabling healthcare providers to accelerate the overall drug discovery process to answer unmet medical needs in oncology.
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Other Pharmaceuticals and Biotechnology
Primary Office
- 5 Avenue du grand sablon
- 38700
- France
+33 04 00 00 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Inovotion’s full profile, request a free trial.
Inovotion Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Grant | 17-Oct-2016 | $55.2K | Completed | Generating Revenue | ||
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Angel (individual) | Completed | Generating Revenue |
Inovotion Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Horizon 2020 | Government | 000 0000 | 000000 0 | |||
| Angelor Capitale | Angel Group | Minority | 000 0000 | 000000 0 | ||
| North Shore InnoVentures | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |